Cargando…
Metastatic Breast Cancer or Multiple Myeloma? Camouflage by Lytic Lesions
We report a case of a female with stage I infiltrating ductal carcinoma who received adjuvant therapy including trastuzumab. One year later she developed lytic lesions and was retreated with trastuzumab that was held after she developed symptomatic heart failure. Lytic lesions were attributed to rel...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833304/ https://www.ncbi.nlm.nih.gov/pubmed/20224644 http://dx.doi.org/10.1155/2010/509530 |